1. Home
  2. ZNTL vs IPI Comparison

ZNTL vs IPI Comparison

Compare ZNTL & IPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZNTL
  • IPI
  • Stock Information
  • Founded
  • ZNTL 2014
  • IPI 2000
  • Country
  • ZNTL United States
  • IPI United States
  • Employees
  • ZNTL N/A
  • IPI N/A
  • Industry
  • ZNTL Biotechnology: Pharmaceutical Preparations
  • IPI Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • ZNTL Health Care
  • IPI Industrials
  • Exchange
  • ZNTL Nasdaq
  • IPI Nasdaq
  • Market Cap
  • ZNTL 105.8M
  • IPI 470.9M
  • IPO Year
  • ZNTL 2020
  • IPI 2008
  • Fundamental
  • Price
  • ZNTL $1.64
  • IPI $27.71
  • Analyst Decision
  • ZNTL Buy
  • IPI Strong Sell
  • Analyst Count
  • ZNTL 6
  • IPI 1
  • Target Price
  • ZNTL $6.53
  • IPI $23.00
  • AVG Volume (30 Days)
  • ZNTL 747.3K
  • IPI 196.5K
  • Earning Date
  • ZNTL 11-11-2025
  • IPI 11-05-2025
  • Dividend Yield
  • ZNTL N/A
  • IPI N/A
  • EPS Growth
  • ZNTL N/A
  • IPI N/A
  • EPS
  • ZNTL N/A
  • IPI N/A
  • Revenue
  • ZNTL $26,865,000.00
  • IPI $225,166,000.00
  • Revenue This Year
  • ZNTL N/A
  • IPI $10.01
  • Revenue Next Year
  • ZNTL N/A
  • IPI N/A
  • P/E Ratio
  • ZNTL N/A
  • IPI N/A
  • Revenue Growth
  • ZNTL N/A
  • IPI 10.53
  • 52 Week Low
  • ZNTL $1.01
  • IPI $20.86
  • 52 Week High
  • ZNTL $4.44
  • IPI $39.01
  • Technical
  • Relative Strength Index (RSI)
  • ZNTL 53.00
  • IPI 43.25
  • Support Level
  • ZNTL $1.49
  • IPI $25.55
  • Resistance Level
  • ZNTL $1.67
  • IPI $28.74
  • Average True Range (ATR)
  • ZNTL 0.11
  • IPI 1.28
  • MACD
  • ZNTL 0.00
  • IPI -0.13
  • Stochastic Oscillator
  • ZNTL 41.43
  • IPI 35.38

About ZNTL Zentalis Pharmaceuticals Inc.

Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.

About IPI Intrepid Potash Inc

Intrepid Potash Inc produces and sells potash and potash byproducts in three main product segments: Potash, Trio, and Oilfield Solutions. The Potash segment produces and sells potash to the agricultural industry as a fertilizer input, the industrial market as a component of oil and gas drilling fluid, and the animal feed market as a nutrient supplement. The Trio segment produces and sells specialty fertilizer that consists of potassium, sulfate, and magnesium and is mined from langbeinite ore. The oilfield solutions segment offers water, high-speed potassium chloride mixing services, saltwater disposal services, and trucking services. The vast majority of revenue is generated in the United States, which is also the location of the firm's production facilities.

Share on Social Networks: